Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  General Surgery
  •  Oral and Maxillofacial Surgery
  •  Ophthalmic Surgery
  •  Cardiovascular Surgery
  •  Surgical Oncology
  •  Robotic Surgery
  •  Vascular Surgery
  •  Gastroenterological Surgery

Abstract

Citation: Clin Surg. 2021;6(1):3197.Research Article | Open Access

ECMO Cannulation Criteria in COVID-19 (ECC-VID) and Obesity: A Literature Review and Retrospective Cohort Analysis

Brian Hassani1*# , Christina Creel-Bulos1#, Michael Connor2 , Mark Caridi-Schieble1 , Casey Miller3 , Mani Danesmand3 and Jeffrey Jadvidfar3

Department of Anesthesiology, Emory Critical Care Center, Emory University School of Medicine, USA 2 Department of Medicine, Emory University School of Medicine, USA 3 Department of Surgery, Emory University School of Medicine, USA # Both authors contributed equally to this work

*Correspondance to: Brian Hassani 

 PDF  Full Text DOI: 10.25107/2474-1647.3197

Abstract

Veno-Venous Extracorporeal Membrane Oxygenation (V-V ECMO) continues to be used as rescue therapy for patients with Acute Respiratory Distress Syndrome (ARDS) secondary to Coronavirus Disease 2019 (COVID-19). Although there is emerging literature on the use of and mortality associated with V-V ECMO in the management of patients with COVID-19, our understanding of who may benefit from this management strategy remains limited. Our clinicians sought to provide further insight into pre-cannulation characteristics and mortality in a cohort of patients with COVID-19 associated ARDS managed with V-V ECMO that primarily consisted of obese patients (90%, n=18) with a BMI of 30 kg/m2 or greater. Our findings not only revealed high survival to hospital discharge (70%, n=14), but demonstrated non-inferior outcomes and survival in obese patients. With an imminent next wave of rising infections, knowledge of which patients have a better chance of survival with the initiation of V-V ECMO is essential. Obese patients have been historically underrepresented in ECMO outcomes literature, but our findings suggest the utilization of ECMO for COVID-19 associated ARDS in these patient subsets should be considered and outcomes should be further explored.

Keywords

V-V ECMO; COVID-19; Obesity; Critical care; Acute respiratory distress syndrome

Cite the article

Hassani B, Creel-Bulos C, Connor M, Caridi-Schieble M, Miller C, Danesmand M, et al. ECMO Cannulation Criteria in COVID-19 (ECC-VID) and Obesity: A Literature Review and Retrospective Cohort Analysis. Clin Surg. 2021; 6: 3197.

Search Our Journal

Journal Indexed In

Articles in PubMed

Mesh Sprayer Device with Liquefied Mesh Delivery System: Proposed Alternative for Currently Available Meshes in Hernia Repair and Supplement to Abdominal Closure
 PubMed  PMC  PDF  Full Text
Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Treatment of Midnight-Noon Ebb-Flow Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Patients with Multiple Myeloma
 Abstract  PDF  Full Text
Laparoscopic Versus Robot Techniques for the Choledochal Cyst in Children: An Initial Meta-Analysis
 Abstract  PDF  Full Text
View More...